Your browser doesn't support javascript.
loading
Establishment of baseline profiles of 50 bile acids in preclinical toxicity species: A comprehensive assessment of translational differences and study design considerations for biomarker development.
Sangaraju, Dewakar; Katavolos, Paula; Liang, Xiaorong; Chou, Carolina; Zabka, Tanja S; Dean, Brian; Maher, Jonathan.
Afiliación
  • Sangaraju D; Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States of America. Electronic address: sangaraju.dewakar@gene.com.
  • Katavolos P; Nonclinical Safety, Bristol Myers Squibb, New Brunswick, NJ, United States of America.
  • Liang X; Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States of America.
  • Chou C; Safety Assessment, Genentech, Inc., Translational Safety Sciences, United States of America.
  • Zabka TS; Safety Assessment, Genentech, Inc., Translational Safety Sciences, United States of America.
  • Dean B; Drug Metabolism & Pharmacokinetics, Genentech, Inc., South San Francisco, CA, United States of America.
  • Maher J; Theravance, South San Francisco, CA, United States of America.
Toxicol Appl Pharmacol ; 443: 116008, 2022 05 15.
Article en En | MEDLINE | ID: mdl-35378153
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácidos y Sales Biliares / Enfermedad Hepática Inducida por Sustancias y Drogas Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácidos y Sales Biliares / Enfermedad Hepática Inducida por Sustancias y Drogas Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Año: 2022 Tipo del documento: Article